Home > News > U.S. Clinical Trial of VivaGel(TM)
October 25th, 2006
U.S. Clinical Trial of VivaGel(TM)
Abstract:
Starpharma Holdings Limited (ASX: SPL) (OTC: SPHRY) today announced that the U.S. site for the clinical trial of SPL7013 gel (VivaGel(TM)) for prevention of genital herpes has opened for recruitment of volunteers.
Source:
prnewswire
Bookmark:
Nanomedicine
Nano-needles for cells May 25th, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
Announcements
Nano-needles for cells May 25th, 2013
How do cold ions slide May 24th, 2013
Gold nanocrystal vibration captured on billion-frames-per-second film May 23rd, 2013
Glowing Plant Releases Maker Kit, Enabling Anyone to Make a Glowing Plant at Home: Glowing Plant seeks funds via crowdfunding and raises almost $400,000 May 23rd, 2013